Lauren Stone, Steven K Grinspoon, Georges El-Fakhri, Kenneth C Williams, Udo Hoffmann, Thomas Brady, Bonnie Abbruzzese, Fred Cope, Amanda Martin, Markella V Zanni, Borek Foldyna, Patrick Autissier, Joshua Walker, Tricia H Burdo, Michael T Lu, Moses Q Wilks, Mabel Toribio
Journal: The Journal of infectious diseases 2017;215(8):1264-1269
PMID: 28204544
BACKGROUND
The ability to noninvasively assess arterial CD206+ macrophages may lead to improved understanding of human immunodeficiency virus (HIV)-associated cardiovascular disease.
METHODS
We trialed a novel macrophage-specific arterial imaging technique.
RESULTS
We demonstrated colocalization between technetium Tc 99m tilmanocept (99mTc-tilmanocept) and CD206+ macrophages ex vivo. In vivo application of 99mTc-tilmanocept single-photon emission computed tomography/computed tomography revealed high-level 99mTc-tilmanocept uptake across 20.4% of the aortic surface volume among HIV-infected subjects, compared with 4.3% among non-HIV-infected subjects (P = .009). Among all subjects, aortic high-level 99mTc-tilmanocept uptake was related to noncalcified aortic plaque volume (r = 0.87; P = .003) on computed tomographic angiography, and this relationship held when we controlled for HIV status.
CONCLUSION
These first-in-human data introduce a novel macrophage-specific arterial imaging technique in HIV.
CLINICAL TRIALS REGISTRATION
NCT02542371.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Full Text Sources:
Medical:
Other Literature Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.